[go: up one dir, main page]

JPWO2022080249A1 - - Google Patents

Info

Publication number
JPWO2022080249A1
JPWO2022080249A1 JP2022556908A JP2022556908A JPWO2022080249A1 JP WO2022080249 A1 JPWO2022080249 A1 JP WO2022080249A1 JP 2022556908 A JP2022556908 A JP 2022556908A JP 2022556908 A JP2022556908 A JP 2022556908A JP WO2022080249 A1 JPWO2022080249 A1 JP WO2022080249A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022556908A
Other languages
Japanese (ja)
Other versions
JPWO2022080249A5 (fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022080249A1 publication Critical patent/JPWO2022080249A1/ja
Publication of JPWO2022080249A5 publication Critical patent/JPWO2022080249A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2022556908A 2020-10-12 2021-10-08 Pending JPWO2022080249A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020171646 2020-10-12
PCT/JP2021/037311 WO2022080249A1 (fr) 2020-10-12 2021-10-08 Agent pour prévenir ou améliorer les affections inflammatoires de l'intestin

Publications (2)

Publication Number Publication Date
JPWO2022080249A1 true JPWO2022080249A1 (fr) 2022-04-21
JPWO2022080249A5 JPWO2022080249A5 (fr) 2024-10-30

Family

ID=81208102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022556908A Pending JPWO2022080249A1 (fr) 2020-10-12 2021-10-08

Country Status (2)

Country Link
JP (1) JPWO2022080249A1 (fr)
WO (1) WO2022080249A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003313173A (ja) * 2002-02-22 2003-11-06 Nippon Zoki Pharmaceut Co Ltd ピペラジン誘導体
WO2009046826A1 (fr) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Utilisation d'un pentapeptide cyclique en tant qu'agent thérapeutique
JP2012214451A (ja) * 2011-03-25 2012-11-08 En Otsuka Pharmaceutical Co Ltd 炎症性疾患用アミノ酸組成物
JP2019214557A (ja) * 2018-06-07 2019-12-19 国立大学法人金沢大学 腎障害の予防又は治療用の医薬組成物
JP2021120359A (ja) * 2020-01-30 2021-08-19 株式会社 資生堂 腸管バリア改善剤
WO2021167032A1 (fr) * 2020-02-18 2021-08-26 学校法人慶應義塾 Médicament et aliment pour traiter et/ou prévenir l'entérite et/ou l'hépatite

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003313173A (ja) * 2002-02-22 2003-11-06 Nippon Zoki Pharmaceut Co Ltd ピペラジン誘導体
WO2009046826A1 (fr) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Utilisation d'un pentapeptide cyclique en tant qu'agent thérapeutique
JP2012214451A (ja) * 2011-03-25 2012-11-08 En Otsuka Pharmaceutical Co Ltd 炎症性疾患用アミノ酸組成物
JP2019214557A (ja) * 2018-06-07 2019-12-19 国立大学法人金沢大学 腎障害の予防又は治療用の医薬組成物
JP2021120359A (ja) * 2020-01-30 2021-08-19 株式会社 資生堂 腸管バリア改善剤
WO2021167032A1 (fr) * 2020-02-18 2021-08-26 学校法人慶應義塾 Médicament et aliment pour traiter et/ou prévenir l'entérite et/ou l'hépatite

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
岡田 かおり ほか: "黒酢及び米酢中のD-及びL-アミノ酸の定量的解析", 微量栄養素研究, vol. 29, JPN6021016344, 2012, pages 62 - 66, ISSN: 0005716172 *
静間 徹 ほか: "黒酢によるデキストラン硫酸ナトリウム誘発性大腸炎の軽減効果", 外科と代謝・栄養, vol. 47, no. 1, JPN6021016343, 2013, pages 1 - 7, ISSN: 0005716171 *

Also Published As

Publication number Publication date
WO2022080249A1 (fr) 2022-04-21

Similar Documents

Publication Publication Date Title
BR112023005462A2 (fr)
BR112023012656A2 (fr)
BR112021014123A2 (fr)
BR112023009656A2 (fr)
BR112022009896A2 (fr)
JPWO2021167032A1 (fr)
BR112023008622A2 (fr)
BR112022024743A2 (fr)
BR112022026905A2 (fr)
BR112023011738A2 (fr)
BR112023004146A2 (fr)
BR112023006729A2 (fr)
BR102021018859A2 (fr)
BR102021015500A2 (fr)
BR112021017747A2 (fr)
BR102021007058A2 (fr)
BR102020022030A2 (fr)
BR112023016292A2 (fr)
BR112023011610A2 (fr)
BR112023011539A2 (fr)
BR112023008976A2 (fr)
JPWO2022080249A1 (fr)
BR102021020147A2 (fr)
BR102021018926A2 (fr)
BR102021018167A2 (fr)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230412

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240920

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240920

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20240920

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240920

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251027